Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
9.63
-0.27 (-2.73%)
At close: Dec 5, 2025, 4:00 PM EST
10.50
+0.87 (9.03%)
After-hours: Dec 5, 2025, 7:23 PM EST
Tango Therapeutics Employees
Tango Therapeutics had 155 employees as of December 31, 2024. The number of employees increased by 15 or 10.71% compared to the previous year.
Employees
155
Change (1Y)
15
Growth (1Y)
10.71%
Revenue / Employee
$429,039
Profits / Employee
-$648,484
Market Cap
1.30B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 155 | 15 | 10.71% |
| Dec 31, 2023 | 140 | 30 | 27.27% |
| Dec 31, 2022 | 110 | 19 | 20.88% |
| Dec 31, 2021 | 91 | 14 | 18.18% |
| Dec 31, 2020 | 77 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
TNGX News
- 9 days ago - Tango Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 14 days ago - Tango Therapeutics: PRMT5 Inhibitor Vopimetostat Approaches Pivotal Testing - Buy - Seeking Alpha
- 5 weeks ago - Is Tango Therapeutics Stock a Buy, Sell, or Hold After Major Shareholder Third Rock Ventures Sold Nearly Half a Million Shares? - The Motley Fool
- 6 weeks ago - Tango Therapeutics, Inc. (TNGX) Discusses Positive Clinical Data and Development Plans for Vopimetostat in MTAP-deleted Cancers Transcript - Seeking Alpha
- 6 weeks ago - Tango Therapeutics Touts Encouraging Data From Early-Stage Cancer Trial, Raises Capital To Fund Advancement - Benzinga
- 6 weeks ago - Tango Therapeutics Announces $225 Million Financing - GlobeNewsWire
- 2 months ago - Tango Therapeutics to Present First Clinical Data from TNG260 at Society for Immunotherapy of Cancer (SITC) Annual Meeting 2025 - GlobeNewsWire
- 3 months ago - Tango Therapeutics to Participate in the 2025 Cantor Global Healthcare Conference - GlobeNewsWire